许家印:恒大新能源汽车能实现2025年产销百万辆目标
恒大主席许家印表示,恒大新能源汽车一定能实现到2025年产销100万辆、2035年产销500万辆的宏伟目标。
许家印连续两日到访深圳恒大全球电池研究院,和上海恒大汽车全球研究总院,指恒大汽车研究总院克服了疫情带来的重重困难和挑战,在研发上取得了显着进展,听取介绍後感到非常振奋。
目前恒大汽车全球研究总院在全球拥有约3,200名科研人员,研究总院内下设前瞻技术研究院、整车技术研究院、软体技术研究院、动力研究院、造型研究院、第一车型 研发院、第二车型研发院、第三车型研发院、全球电池研究院、日本研究院、 瑞典研发中心等11大专业研究院。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.